# Shenzhen Tyercan Biopharm

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/shenzhen-tyercan-biopharm

- Industry: Pharmaceuticals
- Headquarters: Shenzhen, China
- Website: www.tyercan.com
- Latest round: Angel (Jan 24, 2022)
- Investors on record: 5

## About

Based in Shenzhen, China, and established in 2017, Shenzhen Tyercan Biopharm is a pharmaceutical company that focuses on R&D of targeted drugs. The company is a national high-tech company. Moreover, the company established by returnee Doctors team.

The company self-developed peptide-targeted anticancer drugs and targeted immunosuppressive drugs, taking the technologies of peptide drug conjugates (PDC) and peptide testing. Those drugs can be used to cure tumors, organ transplantation, and autoimmunity diseases.

The company plans to promote preclinical studies, Investigational New Drug (IND) application, and clinical phase I/II/III trials of its multiple products.

## Funding rounds

- Angel, Jan 24, 2022 — Tronfund, Sangel Capital, HuaE Finance Management Consultant, Bioching Capital, Shenzhen Zhirong Venture

## Investors

- Tronfund (https://capitalatlas.ai/funds/tronfund) — Angel
- Sangel Capital (https://capitalatlas.ai/funds/sangel-capital) — Angel
- HuaE Finance Management Consultant (https://capitalatlas.ai/funds/huae-finance-management-consultant) — Angel
- Bioching Capital (https://capitalatlas.ai/funds/bioching-capital) — Angel
- Shenzhen Zhirong Venture — Angel